슈말렌베르크 바이러스 치료 시장 : 치료 유형별, 동물 유형별, 최종 사용자별, 지역별

Schmallenberg Virus Treatment Market is estimated to be valued at USD 129.2 Mn in 2025 and is expected to reach USD 227.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2032.

Schmallenberg virus is a pathogen that primarily affects ruminant livestock in Europe, with its name derived from the German town where it was first identified in 2011. This virus is mainly transmitted by Culicoides midges, which serve as vectors for its spread. When livestock, such as cattle, sheep, and goats, are infected, they often display mild to moderate symptoms, including fever, reduced milk production, and decreased fertility. In pregnant animals, particularly cows and ewes, the virus can lead to congenital malformations in the offspring and stillbirths, posing a significant threat to livestock production.The Schmallenberg virus has extended its reach to various European countries, causing economic losses for affected farms due to reduced productivity and reproductive issues. While there is no specific treatment for the virus in animals, prevention and control strategies involve vector control, when possible, as well as vaccination programs in some regions. Notably, the virus primarily affects animals and is not considered a substantial risk to human health. Ongoing research efforts continue to focus on understanding the virus, its transmission dynamics, and the development of more effective vaccines and control measures to safeguard livestock and the agricultural industry from its impact.

Preventing and controlling the Schmallenberg virus involves various measures, including vector control to limit midge exposure, vaccination programs where available, and vigilant monitoring for signs of infection in livestock. It's worth emphasizing that the virus primarily affects animals and does not pose a significant risk to human health. Ongoing research efforts are dedicated to better understanding the virus, its transmission dynamics, and the development of more effective vaccines and control strategies to mitigate its impact on livestock and the agricultural sector in Europe.

Market Dynamics:

Emerging outbreaks, growing awareness, and research and development are anticipated to drive growth of the global Schmallenberg virus treatment market over the forecast period. Moreover, supportive measures are also expected to boost the growth of the global Schmallenberg virus treatment market over the forecast period. Vaccine development, antiviral drugs, supportive care solutions and diagnostic tools are expected to create growth opportunities for the global Schmallenberg virus treatment market during the forecast period.

However, limited treatment options, the complexity of vaccine development, and low economic incentives are expected to hamper growth of the Schmallenberg virus treatment market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the Schmallenberg virus treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Schmallenberg virus treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Boehringer Ingelheim, Zoetis, MSD Animal Health (Merck Animal Health), Elanco Animal Health, Ceva Sante Animale, Virbac, Bayer Animal Health, Vetoquinol, Huvepharma, IDT Biologika, Heska Corporation, Dechra Pharmaceuticals, Phibro Animal Health, Neogen Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Schmallenberg virus treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Schmallenberg virus treatment market

Schmallenberg Virus Treatment Market Detailed Segmentation:

• By Treatment Type:
  • Antiviral Drugs
  • Anti-inflammatory Drugs
  • Analgesics
  • Vaccines
  • Others
• By Animal Type:
  • Cattle
  • Sheep
  • Goats
  • Others
• By End User:
  • Veterinary Hospitals and Clinics
  • Research Institutions
  • Veterinary Pharmacies and Drug Store
  • Others
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profile:
  • Boehringer Ingelheim
  • Zoetis
  • MSD Animal Health (Merck Animal Health)
  • Elanco Animal Health
  • Ceva Sante Animale
  • Virbac
  • Bayer Animal Health
  • Vetoquinol
  • Huvepharma
  • IDT Biologika
  • Heska Corporation
  • Dechra Pharmaceuticals
  • Phibro Animal Health
  • Neogen Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Schmallenberg Virus Treatment, By Treatment Type
  • Market Schmallenberg Virus Treatment, By Animal Type
  • Market Schmallenberg Virus Treatment, By End User
  • Market Schmallenberg Virus Treatment, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Emerging Outbreaks
• Growing Awareness
• Research and Development
• Supportive Measures
  • Restraints
• Limited Treatment Options
• Complexity of Vaccine Development
  • Opportunities
• Vaccine development
• Antiviral Drugs
• Supportive Care Solutions
• Diagnostic Tools
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Schmallenberg Virus Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Schmallenberg Virus Treatment Market, By Treatment Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Antiviral Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Anti-inflammatory Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Schmallenberg Virus Treatment Market, By Animal Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cattle
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Sheep
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Goats
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Schmallenberg Virus Treatment Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Veterinary Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Veterinary Pharmacies and Drug Store
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Schmallenberg Virus Treatment Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
    • GCC
    • Israel
    • North Africa
    • Central Africa
    • Rest of Middle East & Africa

9. Competitive Landscape

• Boehringer Ingelheim
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Zoetis
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• MSD Animal Health (Merck Animal Health)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Elanco Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ceva Sante Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Virbac
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bayer Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vetoquinol
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Huvepharma
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• IDT Biologika
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Heska Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Dechra Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Phibro Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nogen Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us